Joseph Shulman, Chief Technical Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 144,612 shares at $50.14 ($7.3M) on 2024-02-09, disclosed to the SEC on 2024-02-13.
Scheduled sale ($7.3M) by Chief Technical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $48.24 | 100 | $5K | 0.1% |
| 2 | $50.14 | 48,177 | $2.4M | 33.2% |
| 3 | $50.14 | 48,177 | $2.4M | 33.2% |
| 4 | $50.88 | 23,397 | $1.2M | 16.3% |
| 5 | $50.88 | 23,397 | $1.2M | 16.3% |
| 6 | $51.52 | 100 |
| $5K |
| 0.1% |
| 7 | $51.38 | 791 | $41K | 0.6% |
| 8 | $49.84 | 473 | $24K | 0.3% |
| Total | $50.38 avg | 144,612 | $7.3M | 100% |
| Filing → |
| RYTM | SELL | 2025-10-30 | $648K | — | Filing → |
| RYTM | SELL | 2025-10-20 | $3.2M | — | Filing → |
| RYTM | SELL | 2025-09-04 | $3.5M | — | Filing → |